Authors: Zussman, BD Benincosa, LJ Webber, DM Clark, DJ Cowley, H Kelly, J Murdoch, RD Upward, J Wyld, P Port, A Fuder, H

Citation: Bd. Zussman et al., An overview of the pharmacokinetics of cilomilast (Ariflo (R)), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers, J CLIN PHAR, 41(9), 2001, pp. 950-958

Authors: Benincosa, LJ Chow, FS Tobia, LP Kwok, DC Davis, CB Jusko, WJ

Citation: Lj. Benincosa et al., Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys, J PHARM EXP, 292(2), 2000, pp. 810-816

Authors: Tran, JQ Di Cicco, RA Sheth, SB Tucci, M Peng, L Jorkasky, DK Hursting, MJ Benincosa, LJ

Citation: Jq. Tran et al., Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban, J CLIN PHAR, 39(5), 1999, pp. 513-519

Authors: Zia-Amirhosseini, P Minthorn, E Benincosa, LJ Hart, TK Hottenstein, CS Tobia, LAP Davis, CB

Citation: P. Zia-amirhosseini et al., Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonalantibody directed to human interleukin-5, in monkeys, J PHARM EXP, 291(3), 1999, pp. 1060-1067

Authors: Sagawa, K Benincosa, LJ Murer, H Morris, ME

Citation: K. Sagawa et al., Ibuprofen-induced changes in sulfate renal transport, J PHARM EXP, 287(3), 1998, pp. 1092-1097